Live News EQUITY L impact Jul 27, 2026, 04:05 PM UTC

Omeros gains as AstraZeneca's Ultomiris fails in rare blood disorder

Omeros gains as AstraZeneca's Ultomiris fails in rare blood disorder

AZN.L OMERUS.OQ

SquawkNews Newsroom

Omeros gains as AstraZeneca's Ultomiris fails in rare blood disorder